Product Information
GRISEOFULVIN MICRO 500 MG TAB is a generic product labeled by Chartwell RX LLC, priced at $5.8469 per EA under NDC 62135049601. Its NADAC has been published 277 times since Jun 16, 2021.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Chartwell RX LLCNDC
62135049601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GRISEOFULVINApproval Type
Generic (ANDA)
FDA Application
ANDA060569FDA Approved
Before 1982
TE Code
AB
On Market Since
9/9/1971
Pharmacological Classes
Price Statistics
The NADAC for GRISEOFULVIN MICRO 500 MG TAB has been published 277 times since Jun 16, 2021, and over the history we have for it it has declined 24.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.8469 per EA |
|---|---|
| All-time high | $8.2398 (Aug 10, 2022) |
| All-time low | $5.0681 (May 22, 2024) |
| 52-week high | $6.4996 |
| 52-week low | $5.6375 |
| Median price | $6.8622 |
| Average price | $6.9612 |
| Largest weekly change | -27.3% (Apr 17, 2024) |
| Weeks tracked | 277 |
| Tracking since | Jun 16, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
griseofulvin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tubulin Inhibiting Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GRISEOFULVIN MICRO 500 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for GRISEOFULVIN MICRO 500 MG TAB, manufactured by Chartwell RX LLC, is $5.8469 per EA (NDC 62135049601), effective Sep 30, 2026.
How has the price of GRISEOFULVIN MICRO 500 MG TAB changed over time?
Over the history we have for it, the NADAC for GRISEOFULVIN MICRO 500 MG TAB has declined 24.9%. It has been tracked across 277 weekly CMS publications since Jun 16, 2021.
What are the highest and lowest recorded NADAC prices for GRISEOFULVIN MICRO 500 MG TAB?
Since Jun 16, 2021, the NADAC for GRISEOFULVIN MICRO 500 MG TAB has ranged from a low of $5.0681 (May 22, 2024) to a high of $8.2398 (Aug 10, 2022), with a median of $6.8622 per EA.
Are there cheaper alternatives to GRISEOFULVIN MICRO 500 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GRISEOFULVIN MICRO 500 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures GRISEOFULVIN MICRO 500 MG TAB?
GRISEOFULVIN MICRO 500 MG TAB (NDC 62135049601) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.